Clinical Trial Update: Adenosine Receptor Antagonist Combination Therapy for Metastatic Castrate Resistant Prostate Cancer [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update reports the completion of a Phase 1/2 study evaluating an adenosine receptor antagonist in combination therapy for metastatic castrat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Castration-resistant Prostate Cancer

Drugs mentioned

• AB928

Snippet

Sponsor: Arcus Biosciences, Inc. | Conditions: Prostatic Neoplasms, Castration-Resistant, Androgen-Resistant Prostatic Neoplasms | Phase 1, Phase 2 | Status: COMPLETED